Elanco Animal Health (ELAN) Revenue (2017 - 2026)
Elanco Animal Health (ELAN) posted Revenue of $1.4 billion for Q1 2026, up 19.84% sequentially from $1.1 billion in Q4 2025, and up 14.92% YoY from $1.2 billion in Q1 2025.
Elanco Animal Health (ELAN) Revenue (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Revenue for 10 years, with the latest figure at $1.4 billion in Q1 2026.
- Quarterly Revenue rose 14.92% year-over-year to $1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 billion (up 10.53% YoY) and the FY2025 annual result came in at $4.7 billion, up 6.22% from the prior year.
- Revenue climbed to $1.4 billion in Q1 2026 per ELAN's latest filing, from $1.1 billion in the prior quarter.
- Over five years, Revenue peaked at $1.4 billion in Q1 2026 and troughed at $985.0 million in Q4 2022.
- A 5-year average of $1.1 billion and a median of $1.1 billion in 2025 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2026: Revenue slipped 11.42% in 2022, then increased 14.92% in 2026.
- Over 5 years, Revenue stood at $985.0 million in 2022, then advanced by 5.08% to $1.0 billion in 2023, then dropped by 1.45% to $1.0 billion in 2024, then increased by 12.16% to $1.1 billion in 2025, then increased by 19.84% to $1.4 billion in 2026.
- According to Business Quant data, Revenue over the past three periods registered $1.4 billion, $1.1 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 86.50 Bn | 85.53 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.71 Bn | 39.05 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 30.86 Bn | 29.18 Bn | 1.80 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.50 Bn | 22.70 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.06 Bn | 19.40 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.84 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Vireo Growth | 11.86 Bn | 11.71 Bn | 59.30 Mn | 106.20 Mn |
| 9 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 1.37 Bn |
| 10 | HUTCHMED (China) | 10.92 Bn | 9.54 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.37 Bn |
| Mar 31, 2026 | 1.37 Bn |
| Dec 31, 2025 | 1.14 Bn |
| Sep 30, 2025 | 1.14 Bn |
| Jun 30, 2025 | 1.24 Bn |
| Mar 31, 2025 | 1.19 Bn |
| Dec 31, 2024 | 1.02 Bn |
| Sep 30, 2024 | 1.03 Bn |
| Jun 30, 2024 | 1.18 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Dec 31, 2023 | 1.04 Bn |
| Sep 30, 2023 | 1.07 Bn |
| Jun 30, 2023 | 1.06 Bn |
| Mar 31, 2023 | 1.26 Bn |
| Dec 31, 2022 | 985.00 Mn |
| Sep 30, 2022 | 1.03 Bn |
| Jun 30, 2022 | 1.18 Bn |
| Mar 31, 2022 | 1.23 Bn |
| Dec 31, 2021 | 1.11 Bn |
| Sep 30, 2021 | 1.13 Bn |